Neuberger Berman Group Boosts Illumina Stake

Investment firm increases holdings in life sciences company by 14.2%

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Neuberger Berman Group LLC, an investment management firm, grew its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 14.2% during the third quarter, according to a recent disclosure with the Securities and Exchange Commission. Neuberger Berman now owns 65,322 shares of the life sciences company's stock, worth approximately $6.2 million.

Why it matters

Illumina is a leading provider of DNA sequencing systems and related products, playing a key role in the growing field of genomics and precision medicine. Institutional investors' holdings in the company can signal confidence in its long-term prospects.

The details

Neuberger Berman Group increased its Illumina stake by purchasing an additional 8,135 shares during the third quarter. This brings the firm's total holdings in Illumina to 65,322 shares. Other notable investors in Illumina include Empowered Funds LLC, Assetmark Inc., and Bank of Montreal.

  • Neuberger Berman Group disclosed its increased Illumina stake in a filing with the SEC on March 8, 2026.

The players

Neuberger Berman Group LLC

An investment management firm that has increased its stake in Illumina, a leading life sciences company.

Illumina, Inc.

A global life sciences company that develops and markets integrated systems for genetic analysis.

Got photos? Submit your photos here. ›

The takeaway

Neuberger Berman's increased investment in Illumina reflects the firm's confidence in the life sciences company's long-term growth potential within the rapidly evolving genomics and precision medicine industries.